Eagle Pharmaceuticals Inc

NASDAQ:EGRX  
49.70
-1.40 (-2.74%)
Products, Litigation

Endo Comments On Non-Infringement Ruling In VASOSTRICT Patent Litigation

Published: 08/31/2021 18:17 GMT
Eagle Pharmaceuticals Inc (EGRX) - Endo Comments on Non-infringement Ruling in Vasostrict® Patent Litigation.
Endo International Plc - Because Court Found Non-infringement of Endo's Patents by Eagle's Proposed Product, It Did Not Rule on Patents' Validity.
Endo International Plc - to Appeal Court's Decision and Continue Defending Intellectual Property Rights to Vasostrict.